Population-based mechanistic prediction of oral drug absorption

Masoud Jamei, David Turner, Jiansong Yang, Sibylle Neuhoff, Sebastian Polak, Amin Rostami-Hodjegan, Geoffrey Tucker

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The bioavailability of drugs from oral formulations is influenced by many physiological factors including gastrointestinal fluid composition, pH and dynamics, transit and motility, and metabolism and transport, each of which may vary with age, gender, race, food, and disease. Therefore, oral bioavailability, particularly of poorly soluble and/or poorly permeable compounds and those that are extensively metabolized, often exhibits a high degree of inter- and intra-individual variability. While several models and algorithms have been developed to predict bioavailability in an average person, efforts to accommodate intrinsic variability in the component processes are less common. An approach that incorporates such variability for human populations within a mechanistic framework is described together with examples of its application to drug and formulation development. © American Association of Pharmaceutical Scientists 2009.
    Original languageEnglish
    Pages (from-to)225-237
    Number of pages12
    JournalAAPS Journal
    Volume11
    Issue number2
    DOIs
    Publication statusPublished - 2009

    Keywords

    • ADAM
    • ADME
    • In vitro-in vivo extrapolation (IVIVE)
    • Inter-individual variability
    • Oral absorption
    • Physiologically-based pharmacokinetic (PBPK) models

    Fingerprint

    Dive into the research topics of 'Population-based mechanistic prediction of oral drug absorption'. Together they form a unique fingerprint.

    Cite this